Bacil Pharma Limited has received approval from the Registrar of Companies, Central Registration Centre (CRC), Ministry of Corporate Affairs for the name "Bacil Research & Development Private Limited" for its proposed wholly-owned subsidiary. The name approval was received on 6th July, 2026, following an application dated 3rd July, 2026 (SRN AC4364299).
The name approval is valid for a period of 20 days from the approval date, meaning the name will be available until 26th July, 2026. The approval specifies that this is for a New Company (Others) entity type.
The incorporation process of the proposed wholly-owned subsidiary is currently under progress. The company has committed to make necessary disclosures upon completion of the incorporation and receipt of the Certificate of Incorporation from the Registrar of Companies.
The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The ROC approval letter contains important disclaimers stating that the applicant cannot start business or enter into any agreements in the name of the proposed company until the Certificate of Registration is issued. The name is also liable to be withdrawn at any time before registration if found to be improperly allowed.
Key Dates
- Name Application Date: 3rd July, 2026
- Name Approval Date: 6th July, 2026
- Name Validity Until: 26th July, 2026
- Company Intimation Date: 7th July, 2026